1, Koonbo Medical, full name Koonbo Medical Holdings Limited, was founded in 2012, is a high-tech enterprise focusing on the research, development and production of lung disease diagnosis and treatment technology, and has set up several production and research bases in China and the United States.
2. Koonbo Medical mainly researches, develops, produces and sells accurate and minimally invasive interventional diagnostic and therapeutic products for lung cancer, COPD and other lung diseases based on the augmented reality whole-lung navigation technology platform. The Company utilizes its proprietary whole-lung arrival navigation technology to develop a comprehensive interventional respiratory pathology platform that includes navigation and diagnosis, which solves the pain points of the existing diagnostic and treatment modes as well as the huge unmet medical needs of lung diseases by enhancing the diagnostic and treatment effects of lung cancer and chronic obstructive pulmonary disease.
3. KPMC has formed a distribution model centered on China's first-tier cities, covering the whole country, with interconnected development at home and abroad, and its products are sold all over the world. KUNBO has invested more than 63 million dollars in technology and product development. The company's goal is to build a market worth more than RMB 200 billion for interventional lung disease diagnosis and treatment in 10 years and become the market leader.